XML 17 R25.htm IDEA: XBRL DOCUMENT

CONCENTRATIONS

12 Months Ended

Dec. 31, 2011

17.	CONCENTRATIONS

Major Customers

For the year ended December 31, 2011, approximately 13% of the Company’s revenues was received from each of two customers. For the year ended December 31, 2010, approximately 8% of the Company’s revenues was received from one customer.

At December 31, 2011 and 2010, receivables from four customers were approximately 12%, 10%, 9%, 9% and 12%, 11%, 11%, 9%, respectively.

Revenues

For the years ended December 31, 2011 and 2010, the Company’s three top selling products accounted, in the aggregate, for approximately 27% and 53%, respectively, of its total net revenues.

The following represents the revenues by product line, all derived from China:

	For the years ended December 31,
	2011		2010
	US$		US$
Product Lines
Medical Devices		19,362,673		19,157,703
Respiratory and Oxygen Homecare		2,276,610		440,757
		21,639,283		19,598,460

Subsequent Events

On January 10, 2012, the Company entered into a warrant purchase agreement with the Company’s investment consultant, Firs Trust Group, Inc., pursuant to which, the Company issued 100,000 warrants expiring January 10, 2017 to purchase Company’s common shares at $4.00 a share, as compensation for the services. The fair value of the warrants was approximately $98,000, which was calculated by using a fair value option model.

On January 9, 2012, the Company entered into a consulting agreement with an investor relationship consultant, pursuant to which, the Company will grant this consultant 5,000 shares of restricted stock every quarter as compensation for services rendered. The first 5,000 shares were granted on February 13, 2012. The fair value of the shares granted on February 13, 2012 was approximately $11,000 based on the closing price on that date.

On February 2, 2012, the Company entered into a new loan agreement with Nanjing Bank Company Limited (Beijing Branch) in the amount of $792,945 (RMB 5,000,000) with floating interest rate which was approximately 8.2% per year, due on January 30, 2013.